Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma

作者: Bruce L. Dalkin , Frederick R. Ahmann , Joan B. Kopp

DOI: 10.1016/S0022-5347(17)35910-4

关键词:

摘要: In their derivation of normal prostate specific antigen (PSA) levels (0 to 4.0 ng./ml.) Hybritech used almost exclusively men less than 60 years old. The purpose this study was define PSA by age decade in older 50 without clinical evidence prostatic carcinoma or so-called cancer-free. We the cancer-free population as with a equal ng./ml. and nonsuspicious digital rectal examination, those an abnormality either parameter nonmalignant biopsy. A total 755 recruited for cancer detection using serum whom 728 fulfilled our criteria Newly derived mean standard deviation were 1.32 +/- 1.10 59-year group, 1.91 1.72 69-year group 2.36 1.98 70 79-year group. upper limits (mean+2 deviations) 3.5 5.4 6.3 apparent accuracy these new is strong but it declines next decade. data support further attempts at PSA, examination establish selection biopsy adequate sensitivity specificity.

参考文章(9)
John W. Colberg, Deborah S. Smith, William J. Catalona, Prevalence and Pathological Extent of Prostate Cancer in Men with Prostate Specific Antigen Levels of 2.9 to 4.0 NG./ML. Journal of Urology. ,vol. 149, pp. 507- 509 ,(1993) , 10.1016/S0022-5347(17)36130-X
Michael K. Brawer, Michael P. Chetner, Jeanette Beatie, David M. Buchner, Robert L. Vessella, Paul H. Lange, Screening for Prostatic Carcinoma with Prostate Specific Antigen The Journal of Urology. ,vol. 147, pp. 841- 845 ,(1992) , 10.1016/S0022-5347(17)37401-3
Jeffrey I. Miller, Frederick R. Ahmann, George W. Drach, Scott S. Emerson, Manfred R. Bottaccini, The Clinical Usefulness of Serum Prostate Specific Antigen After Hormonal Therapy of Metastatic Prostate Cancer The Journal of Urology. ,vol. 147, pp. 956- 961 ,(1992) , 10.1016/S0022-5347(17)37432-3
William H. Cooner, B.R. Mosley, Charles L. Rutherford, Jeff H. Beard, Harry S. Pond, William J. Terry, Todd C. Igel, Donald D. Kidd, Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen The Journal of Urology. ,vol. 143, pp. 1146- 1152 ,(1990) , 10.1016/S0022-5347(17)40211-4
C. C. Boring, T. S. Squires, T. Tong, Cancer statistics, 1991. CA: A Cancer Journal for Clinicians. ,vol. 41, pp. 19- 36 ,(1991) , 10.3322/CANJCLIN.41.1.19
Jerry J.J. Yuan, Douglas E. Coplen, John A. Petros, Robert S. Figenshau, Timothy L. Ratliff, Deborah S. Smith, William J. Catalona, Effects of Rectal Examination, Prostatic Massage, Ultrasonography and Needle Biopsy on Serum Prostate Specific Antigen Levels The Journal of Urology. ,vol. 147, pp. 810- 814 ,(1992) , 10.1016/S0022-5347(17)37392-5
William J. Catalona, Steven W. Bigg, Nerve-Sparing Radical Prostatectomy: Evaluation of Results after 250 Patients Journal of Urology. ,vol. 143, pp. 538- 543 ,(1990) , 10.1016/S0022-5347(17)40013-9
R. Joseph Babaian, Hiroaki Miyashita, Robert B. Evans, Edilberto I. Ramirez, The Distribution of Prostate Specific Antigen in Men Without Clinical or Pathological Evidence of Prostate Cancer: Relationship to Gland Volume and Age The Journal of Urology. ,vol. 147, pp. 837- 840 ,(1992) , 10.1016/S0022-5347(17)37400-1
George F. Daniels, John E. Mcneal, Thomas A. Stamey, Predictive value of contralateral biopsies in unilaterally palpable prostate cancer. The Journal of Urology. ,vol. 147, pp. 870- 874 ,(1992) , 10.1016/S0022-5347(17)37408-6